Webcast

This webcast will introduce and explain the collaborative initiative between ISMP Canada and Health Canada on the development of a document to support the design of labels* and packages for health products in Canada. This guide is also intended to align and support the Plain Language Labelling Initiative currently underway at Health Canada.

Objective:	To share information on the background and activities to-date in the development of a Guide to Support the Design of Safe Health Product Labels* and Packages
Background:	The purpose of the product label and package is to communicate accurate and current information about the product so that it can be used safely and appropriately to minimize the risk of harm. The guide will identify information to assist manufacturers in the design of labels* and packages that are clear, accurate and understandable. The principles outlined within the guide are also intended to serve as a reference to others (e.g., buying groups) to assist in their assessment of products for purchase. The guide will draw from regulatory and patient safety content, experience and developments in Canada and other jurisdictions.
Audience:	Health product manufacturers and industry associations
Date:	Thursday, September 19, 2013
Duration:	1½ hours
Time:	10:00 am – 11:30 am PDT 11:00 am – 12:30 pm MDT 12:00 pm – 1:30 pm CDT 1:00 pm – 2:30 pm EDT 2:00 pm – 3:30 pm ADT 2:30 pm – 4:00 pm NDT      Time zone map
Cost:	ISMP Canada is pleased to offer this complimentary webcast with support from Health Canada's Canadian Medication Incident Reporting and Prevention System (CMIRPS) Program.
Speakers:	Christine Koczmara Senior Analyst ISMP Canada   Margaret Zimmermann Manager, Patient Safety Section Therapeutic Effectiveness and Policy Bureau Health Canada   Valentina Jelincic Pharmacist, Consultant ISMP Canada
Contact:	webinars@ismp-canada.org

* This refers to the label on or affixed to an immediate container or outside of a package. The product monograph and any other package inclusions are not included in the scope of this project.

Speakers

Christine Koczmara Senior Analyst ISMP Canada

Margaret Zimmermann Manager, Patient Safety Section Therapeutic Effectiveness and Policy Bureau Marketed Health Products Directorate Health Canada

Valentina Jelincic Pharmacist, Consultant ISMP Canada

* This refers to the label on or affixed to an immediate container or outside of a package. The product monograph and any other package inclusions are not included in the scope of this project.

Contact Information